The Annual General Meeting of AddLife AB (publ) will be held as planned on May 7, 2020 and the Board withdraw the dividend proposal AddLife's Board of Directors has decided that the annual general meeting will be held as planned on May 7, 2020. The Board has also decided to withdraw the dividend proposal of SEK 2.40 per share and instead propose that no dividend be paid in connection with the annual general meeting. The Board sees an opportunity to call for an extraordinary general meeting later this year for deciding on a dividend for 2019. Dividend Since the Board of Directors submitted its original dividend proposal on February 6, 2020, the world situation has changed significantly. In the light of the general uncertainty that now prevails and the measures introduced to reduce the spread of Covid-19, AddLife's Board of Directors has decided for precautionary reasons to withdraw the dividend of SEK 2.40 per share and instead propose that no dividend be paid. The Board's decision does not affect AddLife's long-term dividend policy that 30 - 50 percent of profit after tax should be distributed to the shareholders. In recent weeks, AddLife has had a high level of activity with increased demand from the healthcare sector in several of the Group's companies. The Group has a strong financial position and liquidity, and the Board sees an opportunity to call for an extraordinary general meeting later this year for deciding on a dividend for 2019. AGM AddLife's Board of Directors has decided to hold the annual general meeting on May 7, 2020, as previously communicated, since the Swedish Riksdag has decided on provisional rules for annual general meetings during the ongoing outbreak of the virus. AddLife's Board of Directors encourages participants to take advantage of the opportunity to vote by proxy. Further instructions regarding registration via proxies or postal voting will be available on AddLife's website, www.add.life, well in advance of the AGM. For more information, contact; Kristina Willgård, CEO, [email protected], +46 70 510 12 23 www.add.life AddLife is an independent player in the Life Science industry that offers high-quality products, services and advice to both the private and public sectors, mainly in the Nordic region and rest of Europe. AddLife has more than 900 employees in some 45 operating subsidiaries. The Group currently has net sales of around SEK 3.5 billion. AddLife shares are listed on Nasdaq Stockholm. This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 6 April 2020 at 16:15 p.m. CET..